Occurrence of Adverse Effects With Immune Checkpoint Inhibitors Between a Single and Double Dose Regimen
NCT04956783
·
clinicaltrials.gov ↗
COMPLETED
Status
500
Enrollment
OTHER
Sponsor class
Conditions
Cancer
Sponsor
University Hospital, Montpellier